In mouse models of EAE, a B cell-specific deletion of TGF‐β1, resulted in an earlier onset, greater disease burden, and inflammatory cytokine production, illustrating a role of TGF‐β+ Bregs in autoimmune diseases [80]. The gene discussed is TGFB1; the disease is autoimmune disease.